SCHEMBL22945552

SCHEMBL22945552

Cc1ccc(S(=O)(=O)OCCC(F)(F)Cc2ccccc2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.41
ACHE P22303 1/20 0.41
CA12 O43570 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
ATM Q13315 1/20 0.41
CA9 Q16790 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP24A1 Q07973 1/20 0.40
MCHR1 Q99705 1/20 0.40
GAA P10253 1/20 0.39
PKM P14618 1/20 0.39
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
TAS2R14 Q9NYV8 1/20 0.38
LMNA P02545 1/20 0.38
VDR P11473 1/20 0.38
ALDH1A1 P00352 1/20 0.38
NLRP3 Q96P20 1/20 0.38
CNR2 P34972 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30378826 0.85 CA12 (0.42) BCHEACHECA12CYP3A4CA9
SCHEMBL283201 0.79 CA12 (0.42) BCHEACHECA12CYP3A4CA9
SCHEMBL18530435 0.79 STAT3 (0.39) BCHEACHECA12CYP3A4CA9
SCHEMBL6005376 0.79 KIF11 (0.47) BCHEACHECA12CYP1A2CYP3A4
SCHEMBL31122411 0.78 LMNA (0.45) GAAPKMLMNA
SCHEMBL31122455 0.78 P2RX7 (0.45) L3MBTL1LMNA
SCHEMBL23779385 0.78 CA12 (0.41) BCHEACHECA12CYP1A2CYP3A4
SCHEMBL241683 0.78 CA9 (0.54) BCHEACHECA12CYP1A2CYP3A4
SCHEMBL30840744 0.77 ALDH1A1 (0.40) BCHEACHECA12CYP1A2CYP3A4
SCHEMBL13886464 0.77 ALDH1A1 (0.41) BCHEACHECA12CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12338203-B2 Urea compound for antagonizing LPA1 receptor TAISHO PHARMACEUTICAL CO., LTD. (JP) 2025-06-24 US disclosed
EP-4008405-A1 UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR Taisho Pharmaceutical Co., Ltd. (JP) 2022-06-08 EP disclosed
CN-114206832-A Urea compounds antagonizing LPA1 receptor 大正制药株式会社 2022-03-18 CN disclosed
WO-2021020429-A1 UREA COMPOUND FOR ANTAGONIZING LPA1 RECEPTOR 大正製薬株式会社 2021-02-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12338203-B2 Urea compound for antagonizing LPA1 receptor LPAR1, LPAR2, LPAR3 BCHE 3345/4885ACHE 2392/4885CA12 4211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.